APAC to record fastest-growing clinical chemistry market

Currently, North America dominates the market across the globe.

Asia Pacific is projected to have the fastest-growing clinical chemistry market for 2021-2026, with the most rapid emerging markets in nations such as China, Japan, and India and their development of healthcare infrastructure, according to a report from Fortune Business Insights.

Currently, North America is holding the dominant clinical chemistry market share, with its presence of well-established healthcare infrastructure and facilities. Government-supported initiatives and reimbursement facilities will further help this region continue dominance in the coming years as well.

Globally, the increasing prevalence of acute, chronic, and infectious diseases are boosting the clinical chemistry market growth. Further, the rising demand for accurate and quick diagnostic procedures is also expected to ramp up the clinical chemistry market revenue.

Additionally, a sedentary lifestyle, unhealthy eating, and drinking habits are also anticipated to help increase the clinical chemistry market size in the coming years. Also helping is, the rise in disposable incomes of people and the adoption of advanced diagnostic procedures.

On the other hand, the lack of skilled professionals for conducting clinical chemistry tests may hamper the overall clinical chemistry market size. The high cost of clinical chemistry tests could also restrict clinical chemistry market growth in the developing markets.